• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国杭州溶血尿毒综合征患儿的临床特征

Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China.

作者信息

Zhao Shui-Ai, Ning Bo-Tao, Mao Jian-Hua

机构信息

Department of Nephrology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of PICU, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

出版信息

World J Pediatr. 2017 Apr;13(2):183-185. doi: 10.1007/s12519-017-0021-x. Epub 2017 Mar 28.

DOI:10.1007/s12519-017-0021-x
PMID:28353273
Abstract

BACKGROUND

Hemolytic uremic syndrome (HUS) is a main cause of acute renal failure in children. This study aimed to analyze the clinical characteristics of HUS.

METHODS

A retrospective analysis was performed in 46 children with sporadic HUS.

RESULTS

Of the 46 HUS patients, 20 (43.5%) were diarrhea-related HUS, and 26 (56.5%) were atypical HUS. Anemia, edema, oliguria, hemoglobinuria and hypertension were the most common manifestations. Thrombocytopenia, hyponatremia, hypocalcemia, hyperkalemia, metabolic acidosis, increased fibrinogen and hypocomplementemia were found in most patients. The age of onset (younger than 2 years or not, P=0.009), the duration of oliguria or anuria (more than one week or not, P=0.005), accompanied with extrarenal complications or not (P=0.005), dialysis and plasma exchange (P=0.04) were associated with the mortality rate.

CONCLUSIONS

The age of onset younger than 2 years, oliguria/anuria more than 1 week, and associated with extrarenal complications were predictive factors of poor prognosis.

摘要

背景

溶血性尿毒症综合征(HUS)是儿童急性肾衰竭的主要原因。本研究旨在分析HUS的临床特征。

方法

对46例散发性HUS患儿进行回顾性分析。

结果

46例HUS患者中,20例(43.5%)为腹泻相关性HUS,26例(56.5%)为非典型HUS。贫血、水肿、少尿、血红蛋白尿和高血压是最常见的表现。大多数患者存在血小板减少、低钠血症、低钙血症、高钾血症、代谢性酸中毒、纤维蛋白原升高和补体降低。发病年龄(是否小于2岁,P=0.009)、少尿或无尿持续时间(是否超过1周,P=0.005)、是否伴有肾外并发症(P=0.005)、透析及血浆置换(P=0.04)与死亡率相关。

结论

发病年龄小于2岁、少尿/无尿超过1周且伴有肾外并发症是预后不良的预测因素。

相似文献

1
Clinical characteristics of children with hemolytic uremic syndrome in Hangzhou, China.中国杭州溶血尿毒综合征患儿的临床特征
World J Pediatr. 2017 Apr;13(2):183-185. doi: 10.1007/s12519-017-0021-x. Epub 2017 Mar 28.
2
Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.基于人群的队列研究显示,腹泻相关性溶血尿毒综合征的长期预后与 1 年随访时的肾脏损伤标志物相关性差。
Pediatr Nephrol. 2019 Apr;34(4):657-662. doi: 10.1007/s00467-018-4131-z. Epub 2018 Oct 27.
3
[Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].[智利的溶血性尿毒症综合征:临床特征、病程及预后因素]
Rev Med Chil. 2008 Oct;136(10):1240-6. Epub 2009 Jan 15.
4
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
5
Hemolytic-uremic syndrome.溶血尿毒综合征
Pediatr Rev. 2001 Nov;22(11):365-9.
6
[Hemolytic-uremic syndrome (HUS) in children at the University Hospital Center in Dakar: about four cases].[达喀尔大学医院中心儿童溶血性尿毒症综合征(HUS):四例报告]
Pan Afr Med J. 2016 Jun 10;24:138. doi: 10.11604/pamj.2016.24.138.8822. eCollection 2016.
7
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome.少尿和无尿持续时间作为腹泻后溶血尿毒综合征慢性肾脏相关后遗症的预测指标
Pediatr Nephrol. 2008 Aug;23(8):1303-8. doi: 10.1007/s00467-008-0799-9. Epub 2008 May 9.
8
[Hemolytic uremic syndrome: the experience of a pediatric center].[溶血尿毒综合征:一家儿科中心的经验]
Rev Med Chil. 2005 Jul;133(7):781-7. doi: 10.4067/s0034-98872005000700005. Epub 2005 Aug 26.
9
Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.腹泻期间早期容量扩张及随后溶血尿毒综合征期间的相对肾保护作用。
Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. doi: 10.1001/archpediatrics.2011.152. Epub 2011 Jul 22.
10
A clinico-hematological profile of hemolytic-uremic syndrome.溶血尿毒综合征的临床血液学特征
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:280-3.

引用本文的文献

1
Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic-uremic syndrome: a pilot study.志贺毒素 2 诱导的实验性溶血尿毒综合征中的心血管损伤:一项初步研究。
Front Immunol. 2023 Sep 22;14:1252818. doi: 10.3389/fimmu.2023.1252818. eCollection 2023.

本文引用的文献

1
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.终端补体抑制剂依库珠单抗治疗成人非典型溶血尿毒综合征:一项单臂、开放标签试验。
Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.
2
Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death.美国儿童腹泻后溶血尿毒综合征:临床谱及院内死亡的预测因素。
J Pediatr. 2015 Apr;166(4):1022-9. doi: 10.1016/j.jpeds.2014.12.064. Epub 2015 Feb 4.
3
Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
补体因子H遗传和获得性异常的功能评估:在非典型溶血性尿毒症综合征(aHUS)中的应用。
Methods Mol Biol. 2014;1100:237-47. doi: 10.1007/978-1-62703-724-2_19.
4
Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan.日本福岛县26年间溶血性尿毒症综合征的发病率及严重程度指数
Pediatr Int. 2014 Feb;56(1):77-82. doi: 10.1111/ped.12193.
5
Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis.未接受透析治疗的阿根廷溶血性尿毒症综合征患者的长期随访。
Pediatr Nephrol. 2007 Sep;22(9):1343-7. doi: 10.1007/s00467-007-0522-2. Epub 2007 Jun 13.
6
Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome.
Blood Coagul Fibrinolysis. 2006 Oct;17(7):539-44. doi: 10.1097/01.mbc.0000245299.72268.aa.
7
Hemolytic uremic syndrome risk and Escherichia coli O157:H7.溶血尿毒综合征风险与大肠杆菌O157:H7
Emerg Infect Dis. 2005 Dec;11(12):1955-7. doi: 10.3201/eid1112.050607.
8
Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.溶血尿毒综合征患儿肾脏预后不良的危险因素。
Pediatr Nephrol. 2003 Dec;18(12):1229-35. doi: 10.1007/s00467-003-1262-6. Epub 2003 Oct 31.
9
Plasma exchange therapy for the treatment of Escherichia coli O-157 associated hemolytic uremic syndrome.
Int J Mol Med. 2002 Nov;10(5):585-8.
10
Re-evaluating criteria for peritoneal dialysis in "classical" (D+) hemolytic uremic syndrome.
Clin Nephrol. 2001 Feb;55(2):133-42.